Patent details

EP3661514 Title: MAVACAMTEN FOR USE IN THE TREATMENT OF HYPERTROPHIC CARDIOMYOPATHY

Basic Information

Publication number:
EP3661514
PCT Application Number:
US2018045180
Type:
European Patent Granted for LU
Legal Status:
In force
Application number:
EP187592092
PCT Publication Number:
WO2019028360
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
MAVACAMTEN FOR USE IN THE TREATMENT OF HYPERTROPHIC CARDIOMYOPATHY
French Title of Invention:
MAVACAMTEN POUR L'UTILISATION DANS LE TRAITEMENT DE LA CARDIOMYOPATHIE HYPERTROPHIQUE
German Title of Invention:
MAVACAMTEN ZUR VERWENDUNG BEI DER BEHANDLUNG DER HYPERTROPHEN KARDIOMYOPATHIE
SPC Number:

Dates

Filing date:
03/08/2018
Grant date:
17/09/2025
EP Publication Date:
10/06/2020
PCT Publication Date:
07/02/2019
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
17/09/2025
EP B1 Publication Date:
17/09/2025
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
Expiration date:
03/08/2038
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
10/09/2025
 
 

Name:
MyoKardia, Inc.
Address:
1000 Sierra Point Parkway, Brisbane, CA 94005, United States (US)

Agent

Name:
OFFICE FREYLINGER S.A.
From:
17/09/2025
Address:
Boîte Postale 48, L-8001, STRASSEN, Luxembourg (LU)
To:

Inventor

1

Name:
CARLSON, Timothy
Address:
United States (US)

2

Name:
GREEN, Eric
Address:
United States (US)

3

Name:
LEE, June H.
Address:
United States (US)

4

Name:
SEMIGRAN, Marc J.
Address:
United States (US)

5

Name:
LAMBING, Joseph
Address:
United States (US)

6

Name:
EVANCHIK, Marc
Address:
United States (US)

7

Name:
ZHANG, David
Address:
United States (US)

Priority

1

Priority Number:
201762541591 P
Priority Date:
04/08/2017
Priority Country:
United States (US)

2

Priority Number:
201762584537 P
Priority Date:
10/11/2017
Priority Country:
United States (US)

3

Priority Number:
201862639922 P
Priority Date:
07/03/2018
Priority Country:
United States (US)

4

Priority Number:
201862671585 P
Priority Date:
15/05/2018
Priority Country:
United States (US)

Classification

IPC classification:
A61K 31/513; A61P 9/04; A61P 9/10;

Publication

European Patent Bulletin

1

Issue number:
202538
Publication date:
17/09/2025
Description:
Grant (B1)

2

Issue number:
202539
Publication date:
24/09/2025
Description:
Application number/publication number of the divisional application (Art. 76) changed

Annual Fees

Annual Fee Due Date:
31/08/2026
Annual Fee Number:
9
Annual Fee Amount:
115 Euro
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages
17/09/2025 Power Of Attorney 1
18/09/2025 Outgoing Correspondence 1